Ventyx Biosciences Inc (VTYX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Operating Expenses | 148,450 | 207,994 | 113,136 | 67,147 | 7,050 |
| Operating Income | -148,450 | -207,994 | -113,136 | -67,147 | -7,050 |
| Interest Expense | 0 | 0 | 0 | 99 | 358 |
| Other Income | 13,328 | 15,032 | 4,710 | -16,500 | -20,766 |
| Pre-tax Income | -135,122 | -192,962 | -108,426 | -83,746 | -28,174 |
| Net Income Continuous | -135,122 | -192,962 | -108,426 | -83,746 | -28,174 |
| Net Income | $-135,122 | $-192,962 | $-108,426 | $-83,746 | $-28,174 |
| EPS Basic Total Ops | -1.97 | -3.30 | -2.07 | -6.65 | -14.17 |
| EPS Basic Continuous Ops | -1.97 | -3.30 | -2.07 | -6.53 | -14.16 |
| EPS Diluted Total Ops | -1.97 | -3.30 | -2.07 | -6.65 | -14.17 |
| EPS Diluted Continuous Ops | -1.97 | -3.30 | -2.07 | -6.53 | -14.16 |
| EPS Diluted Before Non-Recurring Items | -1.97 | -3.30 | -2.07 | -6.65 | N/A |
| EBITDA(a) | $-147,102 | $-207,053 | $-112,666 | $-67,117 | $-7,050 |